Bile acids in hepatobiliary disease:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Dordrecht [u.a.]
Kluwer Acad. Publ.
2000
|
| Schriftenreihe: | Falk Symposium: Falk Symposium
110,B |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XIII, 339 S. graph. Darst. |
| ISBN: | 0792387554 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV013284635 | ||
| 003 | DE-604 | ||
| 005 | 20000803 | ||
| 007 | t | ||
| 008 | 000803s2000 d||| |||| 10||| eng d | ||
| 020 | |a 0792387554 |9 0-7923-8755-4 | ||
| 035 | |a (OCoLC)231852416 | ||
| 035 | |a (DE-599)BVBBV013284635 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 | ||
| 245 | 1 | 0 | |a Bile acids in hepatobiliary disease |c ed. by T. C. Northfield ... |
| 264 | 1 | |a Dordrecht [u.a.] |b Kluwer Acad. Publ. |c 2000 | |
| 300 | |a XIII, 339 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Falk Symposium: Falk Symposium |v 110,B | |
| 650 | 0 | 7 | |a Leberkrankheit |0 (DE-588)4034937-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Ursodesoxycholsäure |0 (DE-588)4290095-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gallenwegskrankheit |0 (DE-588)4124902-1 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1999 |z London |2 gnd-content | |
| 689 | 0 | 0 | |a Leberkrankheit |0 (DE-588)4034937-8 |D s |
| 689 | 0 | 1 | |a Ursodesoxycholsäure |0 (DE-588)4290095-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Gallenwegskrankheit |0 (DE-588)4124902-1 |D s |
| 689 | 1 | 1 | |a Ursodesoxycholsäure |0 (DE-588)4290095-5 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Northfield, Tim |e Sonstige |4 oth | |
| 830 | 0 | |a Falk Symposium: Falk Symposium |v 110,B |w (DE-604)BV000001125 |9 110,B | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009056763&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-009056763 | ||
Datensatz im Suchindex
| _version_ | 1804128051853787136 |
|---|---|
| adam_text | Contents
List of Principal Authors ix
Introduction xiii
T.C. Northfield
SECTION I: CHOLESTATIC LIVER DISEASE:
PHYSIOLOGY, PATHOGENESIS AND EPIDEMIOLOGY
1 Cellular and molecular mechanisms of bile salt
transport in health and disease 3
J.L. Boyer
2 Effect of bile duct ligation and bile salts on the activity
of 11/3 hydroxysteroid dehydrogenase: another
explanation for mineralocorticoid excess in biliary
cirrhosis in the rat 6
J. Reichen, B. Frey, F.J. Frey
3 Immunological aspects of cholestatic liver disease 13
M.F. Bassendine, D.E.J. Jones
SECTION II: BILE ACID THERAPY
4 The optimum dose of ursodeoxycholic acid in
primary biliary cirrhosis 25
A. Verma, R.P. Jazrawi, H.A. Ahmed, T.C. Northfield
5 Ursodeoxycholic acid an immunomodulator in
primary biliary cirrhosis? 30
A.G. Urn, R.P. Jazrawi, H.A. Ahmed, T.C. Northfield
V
CONTENTS
SECTION III: CLINICAL TRIALS
6 Primary biliary cirrhosis: long term management
with ursodeoxycholic acid 39
J. Heathcote
7 Management of patients with primary sclerosing cholangitis 47
A Stiehl, C. Benz, P. Sauer
SECTION IV: OTHER CHOLESTATIC CONDITIONS
8 The genetics of bile acid transport 53
ft Thompson
9 Congenital defects in bile acid synthesis cause a spectrum
of diseases manifest as severe cholestasis, neurological
disease, and fat soluble vitamin malabsorption 57
K.D.R. Setchell, N.C. O Connell, R.H. Squires,
J.E. Heubi
10 The liver in cystic fibrosis 66
C. Colombo, S. Comi and N. Bettinardi
11 Canalicular secretion of lysyl fluorescein bile acids in
17/3 estradiol glucuronide (170EG) induced cholestasis:
protective effect of s adenosyl L methionine (SAMe) 72
P. Milkiewicz, CO. Mills, M.G. Roma,
J. Ahmed Choudhury, R. Coleman, E. Elias
SECTION V: ALCOHOLIC AND OTHER LIVER DISEASES
12 Ethanol metabolism 87
T.J. Peters, V.R. Preedy
13 Alcohol abuse and abstinence 91
H. Ghodse, C. Drummond
14 Pathogenesis of alcoholic liver disease 100
C.S. Lieber
15 Clinical aspects of alcoholic liver disease 136
ft Williams
SECTION VI: BILE ACID THERAPY
16 Ursodeoxycholic acid in the treatment of alcoholic
liver disease 147
J.N. Plevris, P.C. Hayes, I.A.D. Bouchier
vi
CONTENTS
17 Fibrosis markers and ursodeoxycholic acid 153
J.M.C. Stenner, R.P. Jazrawi, H.A. Ahmed,
A. Verma, T.C. Northfield
18 Ursodeoxycholic acid for treatment of chronic
hepatitis C: an interferon sparing effect 159
A. Lanzini, M.G. Pigozzi, L Distefano, A. Reggiani,
G.P. Lorini, R Sorbara, M.G. De Tavonatti, L. Bettini,
G. Montani, O. Baisini, F. Lanzarotto, D. Quatrocchi,
A. Cominotti, M. Favret
SECTION VII: CHOLESTEROL GALLSTONE DISEASE
19 Pathogenesis of cholesterol gallstone disease: role
of the liver 165
B. Paigen, M.C. Carey
20 Pathogenesis of gallstones: events in bile 174
T. Gilat, G. Somjen, F. Konikoff
21 Role of the gallbladder in the pathogenesis of
gallstone disease 182
R.P. Jazrawi, P. Pazzi, M.L. Petroni, H.A. Ahmed,
T.C. Northfield
22 The role of the large intestine in cholesterol gallstone
formation 192
K.W. Heaton
23 The octreotide model 200
ft/ /. Dowling, H. Hussaini, M. Veysey, L. Thomas,
G. French, J. Wass, G. Murphy
SECTION VIII: THERAPY
24 Oral bile acid therapy 213
E. Roda, A. Colecchia, G. Mazzella, A. Larocca,
L Sandri, F. Romano, D. Festi
25 Cholesterol solvents for topical gallstone dissolution 219
U. Leuschner
26 Mechanisms of dissolution of cholesterol gallstones 226
H.A. Ahmed, R.P. Jazrawi, G. Lauffer, T.C. Northfield
vii
CONTENTS
27 Extracorporeal shock wave lithotripsy of gallstones 236
G.H. Sauter, M. Sackmann, G. Paumgartner
28 Management of gallstone recurrence 240
T.C. Northfield, M.L. Petroni, R.P. Jazrawi
29 Laparoscopic cholecystectomy 248
A.G. Johnson
30 Combination of ursodeoxycholic acid and
chenodeoxycholic acid for dissolution of
cholesterol gallstones 254
M.L. Petroni, R.P. Jazrawi, A. Lanzini, P. Pazzi,
H.A. Ahmed, T.C. Northfield
SECTION IX: OTHER CONDITIONS
31 Role of bile acids in colonic neoplasia: experimental
animal studies 263
C.A. Einarsson
32 Role of bile acids in colonic neoplasia human studies 268
M. Stellini, M.J. Veysey, LA. Thomas, V. Milovic,
P.J. Jenkins, P. Fairclough, G. M. Murphy, R.H. Dowling
SECTION X: CHRONIC PANCREATITIS
33 Bile acids in pancreatic steatorrhoea 277
PL. Zentler Munro
34 Impaired uptake of long chain fatty acids contributes
to fat malabsorption in paediatric patients with cystic
fibrosis 286
H.J. Verkade, DM Minich, C.M.A. Bijleveld,
W.M.C. vanAalderen, F. Stellaard, R.J. Vonk,
M. Laseur, M. Kalivianakis
SECTION XI: CONCLUDING LECTURE
35 Bile acid science (cholanology) at the dawn of a
new millennium: past progress and challenges
for the future 303
A.F. Hofmann
Index 333
viii
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV013284635 |
| ctrlnum | (OCoLC)231852416 (DE-599)BVBBV013284635 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01673nam a2200409 cb4500</leader><controlfield tag="001">BV013284635</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20000803 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">000803s2000 d||| |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0792387554</subfield><subfield code="9">0-7923-8755-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)231852416</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV013284635</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Bile acids in hepatobiliary disease</subfield><subfield code="c">ed. by T. C. Northfield ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Dordrecht [u.a.]</subfield><subfield code="b">Kluwer Acad. Publ.</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIII, 339 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Falk Symposium: Falk Symposium</subfield><subfield code="v">110,B</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Leberkrankheit</subfield><subfield code="0">(DE-588)4034937-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Ursodesoxycholsäure</subfield><subfield code="0">(DE-588)4290095-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gallenwegskrankheit</subfield><subfield code="0">(DE-588)4124902-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1999</subfield><subfield code="z">London</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Leberkrankheit</subfield><subfield code="0">(DE-588)4034937-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Ursodesoxycholsäure</subfield><subfield code="0">(DE-588)4290095-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Gallenwegskrankheit</subfield><subfield code="0">(DE-588)4124902-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Ursodesoxycholsäure</subfield><subfield code="0">(DE-588)4290095-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Northfield, Tim</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Falk Symposium: Falk Symposium</subfield><subfield code="v">110,B</subfield><subfield code="w">(DE-604)BV000001125</subfield><subfield code="9">110,B</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009056763&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009056763</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1999 London gnd-content |
| genre_facet | Konferenzschrift 1999 London |
| id | DE-604.BV013284635 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:43:06Z |
| institution | BVB |
| isbn | 0792387554 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-009056763 |
| oclc_num | 231852416 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | XIII, 339 S. graph. Darst. |
| publishDate | 2000 |
| publishDateSearch | 2000 |
| publishDateSort | 2000 |
| publisher | Kluwer Acad. Publ. |
| record_format | marc |
| series | Falk Symposium: Falk Symposium |
| series2 | Falk Symposium: Falk Symposium |
| spelling | Bile acids in hepatobiliary disease ed. by T. C. Northfield ... Dordrecht [u.a.] Kluwer Acad. Publ. 2000 XIII, 339 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Falk Symposium: Falk Symposium 110,B Leberkrankheit (DE-588)4034937-8 gnd rswk-swf Ursodesoxycholsäure (DE-588)4290095-5 gnd rswk-swf Gallenwegskrankheit (DE-588)4124902-1 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1999 London gnd-content Leberkrankheit (DE-588)4034937-8 s Ursodesoxycholsäure (DE-588)4290095-5 s DE-604 Gallenwegskrankheit (DE-588)4124902-1 s Northfield, Tim Sonstige oth Falk Symposium: Falk Symposium 110,B (DE-604)BV000001125 110,B HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009056763&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Bile acids in hepatobiliary disease Falk Symposium: Falk Symposium Leberkrankheit (DE-588)4034937-8 gnd Ursodesoxycholsäure (DE-588)4290095-5 gnd Gallenwegskrankheit (DE-588)4124902-1 gnd |
| subject_GND | (DE-588)4034937-8 (DE-588)4290095-5 (DE-588)4124902-1 (DE-588)1071861417 |
| title | Bile acids in hepatobiliary disease |
| title_auth | Bile acids in hepatobiliary disease |
| title_exact_search | Bile acids in hepatobiliary disease |
| title_full | Bile acids in hepatobiliary disease ed. by T. C. Northfield ... |
| title_fullStr | Bile acids in hepatobiliary disease ed. by T. C. Northfield ... |
| title_full_unstemmed | Bile acids in hepatobiliary disease ed. by T. C. Northfield ... |
| title_short | Bile acids in hepatobiliary disease |
| title_sort | bile acids in hepatobiliary disease |
| topic | Leberkrankheit (DE-588)4034937-8 gnd Ursodesoxycholsäure (DE-588)4290095-5 gnd Gallenwegskrankheit (DE-588)4124902-1 gnd |
| topic_facet | Leberkrankheit Ursodesoxycholsäure Gallenwegskrankheit Konferenzschrift 1999 London |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009056763&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000001125 |
| work_keys_str_mv | AT northfieldtim bileacidsinhepatobiliarydisease |